公司资料
Talaris Therapeutics 股价、新闻与催化剂
- 股票代码:
- TRML
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for TRML.
公司概览
业务概览
Talaris Therapeutics was a cell-therapy company focused on immune tolerance and transplant-related science before its public-market decline and restructuring. Its platform aimed to improve how cell therapy could support transplantation.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ before restructuring, Talaris sat in advanced cell therapy.
商业模式特征
The business depended on clinical development, platform validation, and the strategic value of its immune-tolerance approach.
生物医药行业定位
Talaris belongs to the historical cell-therapy category rather than the current live public-company set.
未来催化剂
- Talaris is now a legacy / closeout story, so the catalysts are any residual transaction or portfolio-resolution update. There is no active standalone pipeline driving it.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。